Oxford Endovascular is developing OxiFlow™, a next-generation flow diverter that redirects blood flow away from intracranial aneurysms at risk of rupture, enhancing placement accuracy and safety. This technology addresses the critical issue of brain hemorrhage, which affects 1 in 50 individuals, by making more patients eligible for effective treatment.
Funding
$25.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Intracranial aneurysms, affecting 1 in 50 people, pose a significant risk of brain hemorrhage, leading to high mortality and permanent brain damage. Existing flow diverters used to treat these aneurysms can be difficult to place accurately and safely, leading to complications and often requiring multiple devices.
Solution
Oxford Endovascular is developing OxiFlow™, a next-generation flow diverter designed to improve the treatment of intracranial aneurysms and reduce the risk of brain hemorrhage. Inspired by origami engineering, OxiFlow™ is laser-cut from Nitinol, a nickel titanium alloy known for its superior memory and design capabilities. Its unique construction allows for more accurate and reliable placement, conforming better to the patient’s blood vessels and reducing complications compared to existing flow diverters. By diverting blood flow away from the aneurysm, OxiFlow™ promotes shrinking and healing, offering a safer and more effective treatment option.
Target Audience
The primary target audience includes neurovascular surgeons and interventional neuroradiologists specializing in the treatment of brain aneurysms.
Features
- Novel flow-diverter stent designed for treating intracranial aneurysms at risk of rupture
- Origami-inspired engineering for enhanced placement accuracy and reliability
- Laser-cut from Nitinol for superior memory and design capabilities
- Minimally invasive groin access for insertion into brain blood vessels
- Conforms to patient-specific blood vessel anatomy
- Reduces the risk of complications associated with current flow diverters